Zhenghong Gao
About Zhenghong Gao
Zhenghong Gao serves as the Director of Non-Viral Delivery at Asklepios BioPharmaceutical, Inc. since 2022, with a background in materials physics and chemistry, and extensive experience in research and academia.
Work at Asklepios BioPharmaceutical
Zhenghong Gao serves as the Director of Non-Viral Delivery at Asklepios BioPharmaceutical, Inc. (AskBio) since 2022. In this role, he focuses on advancing non-viral delivery systems for gene therapy, contributing to the company's mission of developing innovative treatments. His expertise in this area is crucial for the development of therapies targeting various diseases, particularly neurological conditions.
Education and Expertise
Zhenghong Gao holds a Doctor of Philosophy (PhD) in Advanced Interdisciplinary Studies with a focus on nanomaterials from The University of Tokyo, obtained from 2009 to 2012. He also earned a Master's degree in Materials Physics and Chemistry from Lanzhou University between 2005 and 2008, and a Bachelor's degree in Physics of Materials from the same institution from 2001 to 2005. His educational background provides a solid foundation for his research in nanobiomedicine and gene therapy.
Background in Research and Academia
Zhenghong Gao has extensive experience in research and academia. He worked as a Principal Investigator and Research Scientist at The University of Texas at Dallas from 2019 to 2021, and briefly as an Assistant Professor there in 2021-2022. His previous roles include Research Fellow at the University of Michigan from 2015 to 2018 and Research Scholar at CNRS in Bordeaux, France, from 2012 to 2015. These positions have contributed to his expertise in multidisciplinary research.
Achievements in Scientific Research
Zhenghong Gao has a proven track record in leading multidisciplinary R&D projects, including serving as principal investigator on initiatives involving viral AAV and lipid nano-platforms for CRISPR gene therapy delivery. His work specifically targets neurological diseases by addressing challenges such as the blood-brain barrier. He has also been involved in the development and translation of a peptide to clinical trials, demonstrating his capabilities in translational research.
Publications and Contributions to Science
Zhenghong Gao has published over 25 articles in scientific journals and has delivered more than 40 presentations at various conferences. His contributions to the scientific community reflect his active engagement and influence in the fields of nanobiomedicine and gene therapy. Additionally, he holds a US patent application for a liquid biopsy technology, underscoring his innovative work in biomedical research.